Internal Medicine, Endocrinology, Diabetes, & Metabolism · Folsom, CA
NPI
1649458803
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1730 Prairie City Rd Ste 120
Folsom, CA, 95630
Phone (916) 351-4800
Groups this clinician bills Medicare through
Medicare paid, 2024
$412K
17,651 services
Medicare patients, 2024
729
Average age 73
Drug cost, 2024
$3.0M
5,226 prescriptions
Company payments, 2025
$318
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Efrem H Gebremedhin was code J0897 (injection, denosumab, 1 mg), 7,080 times for 74 patients. In total Efrem H Gebremedhin billed 17,651 services in 25 codes, and Medicare paid $412K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 7,080 | 74 | $20.46 | $145K |
| 99214 Office E&M - Established | Office | 1,086 | 585 | $105.28 | $114K |
| 95251 Test - Miscellaneous | Office | 354 | 127 | $26.90 | $9,521 |
| 83036 Blood Count | Office | 300 | 165 | $9.38 | $2,814 |
| 99215 Office E&M - Established | Office | 262 | 150 | $144.95 | $38K |
| 96372 Injection Administration | Office | 173 | 87 | $12.50 | $2,162 |
| 99204 Office E&M - New | Office | 148 | 148 | $136.06 | $20K |
| 99091 E&M - Miscellaneous | Office | 22 | 16 | $46.63 | $1,026 |
| 95117 Treatment - Miscellaneous | Office | 17 | 14 | $6.88 | $117 |
| 95249 Test - Miscellaneous | Office | 16 | 14 | $50.90 | $814 |
By year: 2022 $204K for 6,257 services; 2023 $401K for 21,117 services; 2024 $412K for 17,651 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 300 | 165 | $9.38 | $2,814 |
Medicare prescription drug claims, 2024
In 2024, the drug Efrem H Gebremedhin prescribed most often to Medicare patients was Levothyroxine Sodium, with 714 prescriptions and refills. In total Efrem H Gebremedhin wrote 5,226 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 714 | 2,033 | 199 | $9,066 |
| Ozempic Semaglutide | 632 | 870 | 115 | $794K |
| Mounjaro Tirzepatide | 293 | 362 | 61 | $378K |
| Metformin Hcl Generic | 182 | 530 | 67 | $1,960 |
| Jardiance Empagliflozin | 180 | 367 | 45 | $206K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 166 | 448 | 64 | $27K |
| Alendronate Sodium Generic | 148 | 399 | 50 | $1,172 |
| Atorvastatin Calcium Generic | 143 | 421 | 47 | $1,587 |
| Tresiba Flextouch U-200 Insulin Degludec | 119 | 280 | 35 | $185K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 106 | 272 | 53 | $14K |
| Methimazole Generic | 99 | 270 | 32 | $1,297 |
| Testosterone Generic | 97 | 130 | 20 | $21K |
| Metformin Hcl Er Metformin Hcl | 95 | 237 | 25 | $1,327 |
| Tymlos Abaloparatide | 94 | 108 | 12 | $282K |
| Synthroid Levothyroxine Sodium | 93 | 279 | 26 | $8,245 |
Brand drugs: 2,755 claims; generic drugs: 2,080 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Efrem H Gebremedhin $318 ($318 in general payments such as food, travel and fees) from 3 companies. The largest payer was Sequel Med Tech, LLC with $159.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.